
Gliford M 1mg/500mg Tablet ER
Marketer
Crossford Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Gliford M 1mg/500mg Tablet ER
Diabexe Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks, juice) are preventive measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Disclose any history of heart disease to your physician before starting treatment. Pregnant or breastfeeding individuals must consult their doctor. Regular blood sugar monitoring and potential blood tests (blood cell counts, liver function) are recommended.
Uses of Gliford M 1mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Gliford M 1mg/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gliford M 1mg/500mg Extended-Release tablets should be administered with a meal.
Common Side effects of Gliford M 1mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Gliford M 1mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. It is recommended to take Gliford M 1mg/500mg Extended-Release Tablet with food.
How Gliford M 1mg/500mg Tablet ER works:
Gliford M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gliford M 1mg/500mg Extended-Release tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Gliford M tablets (1mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Gliford M 1mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Gliford M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Gliford M 1mg/500mg Extended-Release tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gliford M 1mg/500mg Extended-Release tablets cautiously, potentially requiring dose modification. Consult a physician. In those with mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Gliford M 1mg/500mg Tablet ER :
Should you forget a Gliford M 1mg/500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliford M 1mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
